A comparative study of thulium laser resection of the prostate and bipolar transurethral plasmakinetic prostatectomy for treating benign prostatic hyperplasia.
Identifieur interne : 000333 ( PubMed/Curation ); précédent : 000332; suivant : 000334A comparative study of thulium laser resection of the prostate and bipolar transurethral plasmakinetic prostatectomy for treating benign prostatic hyperplasia.
Auteurs : Bo Peng [République populaire de Chine] ; Guang-Chun Wang ; Jun-Hua Zheng ; Sheng-Qiang Xia ; Jiang Geng ; Jian-Ping Che ; Yang Yan ; Jian-Hua Huang ; Yun-Fei Xu ; Bin YangSource :
- BJU international [ 1464-410X ] ; 2013.
Descripteurs français
- KwdFr :
- Adulte d'âge moyen, Complications postopératoires (physiopathologie), Douleur postopératoire (physiopathologie), Durée du séjour, Humains, Hyperplasie de la prostate (), Hyperplasie de la prostate (anatomopathologie), Lasers à solide (usage thérapeutique), Mâle, Qualité de vie, Résection transuréthrale de prostate (), Satisfaction du patient (), Sujet âgé, Sujet âgé de 80 ans ou plus, Sécurité des patients, Taille d'organe, Thulium (usage thérapeutique), Thérapie laser (), Études de suivi, Évaluation des risques.
- MESH :
- anatomopathologie : Hyperplasie de la prostate.
- physiopathologie : Complications postopératoires, Douleur postopératoire.
- usage thérapeutique : Lasers à solide, Thulium.
- Adulte d'âge moyen, Durée du séjour, Humains, Hyperplasie de la prostate, Mâle, Qualité de vie, Résection transuréthrale de prostate, Satisfaction du patient, Sujet âgé, Sujet âgé de 80 ans ou plus, Sécurité des patients, Taille d'organe, Thérapie laser, Études de suivi, Évaluation des risques.
English descriptors
- KwdEn :
- Aged, Aged, 80 and over, Follow-Up Studies, Humans, Laser Therapy (methods), Lasers, Solid-State (therapeutic use), Length of Stay, Male, Middle Aged, Organ Size, Pain, Postoperative (physiopathology), Patient Safety, Patient Satisfaction (statistics & numerical data), Postoperative Complications (physiopathology), Prostatic Hyperplasia (pathology), Prostatic Hyperplasia (surgery), Quality of Life, Risk Assessment, Thulium (therapeutic use), Transurethral Resection of Prostate (methods).
- MESH :
- chemical , therapeutic use : Thulium.
- methods : Laser Therapy, Transurethral Resection of Prostate.
- pathology : Prostatic Hyperplasia.
- physiopathology : Pain, Postoperative, Postoperative Complications.
- statistics & numerical data : Patient Satisfaction.
- surgery : Prostatic Hyperplasia.
- therapeutic use : Lasers, Solid-State.
- Aged, Aged, 80 and over, Follow-Up Studies, Humans, Length of Stay, Male, Middle Aged, Organ Size, Patient Safety, Quality of Life, Risk Assessment.
Abstract
WHAT'S KNOWN ON THE SUBJECT? AND WHAT DOES THE STUDY ADD?: Thulium laser is a new generation of surgical laser. It is a minimally invasive technology with several advantages, including rapid vaporization and minimal tissue damage and bleeding. However, details regarding the safety and efficacy of thulium laser in treating BPH remains unknown. We performed a comparative study in 100 patients with BPH of the safety and efficacy of thulium laser resection of the prostate (TMLRP, n = 50) and bipolar transurethral plasmakinetic prostatectomy (TUPKP, n = 50). We found that the efficacy and indications were the same in TMLRP and TUPKP. In TUPKP, the morbidity of urethrostenosis was low, and was nearly bloodless in surgery and had higher safety. Nevertheless, TUPKP is more suitable for patients with larger prostate volume.
DOI: 10.1111/j.1464-410X.2012.11610.x
PubMed: 23107074
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: Pour aller vers cette notice dans l'étape Curation :000333
Links to Exploration step
pubmed:23107074Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">A comparative study of thulium laser resection of the prostate and bipolar transurethral plasmakinetic prostatectomy for treating benign prostatic hyperplasia.</title><author><name sortKey="Peng, Bo" sort="Peng, Bo" uniqKey="Peng B" first="Bo" last="Peng">Bo Peng</name><affiliation wicri:level="1"><nlm:affiliation>Department of Urology, Shanghai Tenth People's Hospital of Tongji University, Shanghai, 200072, P.R. China.</nlm:affiliation><country xml:lang="fr" wicri:curation="lc">République populaire de Chine</country><wicri:regionArea>Department of Urology, Shanghai Tenth People's Hospital of Tongji University, Shanghai, 200072</wicri:regionArea></affiliation></author><author><name sortKey="Wang, Guang Chun" sort="Wang, Guang Chun" uniqKey="Wang G" first="Guang-Chun" last="Wang">Guang-Chun Wang</name></author><author><name sortKey="Zheng, Jun Hua" sort="Zheng, Jun Hua" uniqKey="Zheng J" first="Jun-Hua" last="Zheng">Jun-Hua Zheng</name></author><author><name sortKey="Xia, Sheng Qiang" sort="Xia, Sheng Qiang" uniqKey="Xia S" first="Sheng-Qiang" last="Xia">Sheng-Qiang Xia</name></author><author><name sortKey="Geng, Jiang" sort="Geng, Jiang" uniqKey="Geng J" first="Jiang" last="Geng">Jiang Geng</name></author><author><name sortKey="Che, Jian Ping" sort="Che, Jian Ping" uniqKey="Che J" first="Jian-Ping" last="Che">Jian-Ping Che</name></author><author><name sortKey="Yan, Yang" sort="Yan, Yang" uniqKey="Yan Y" first="Yang" last="Yan">Yang Yan</name></author><author><name sortKey="Huang, Jian Hua" sort="Huang, Jian Hua" uniqKey="Huang J" first="Jian-Hua" last="Huang">Jian-Hua Huang</name></author><author><name sortKey="Xu, Yun Fei" sort="Xu, Yun Fei" uniqKey="Xu Y" first="Yun-Fei" last="Xu">Yun-Fei Xu</name></author><author><name sortKey="Yang, Bin" sort="Yang, Bin" uniqKey="Yang B" first="Bin" last="Yang">Bin Yang</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2013">2013</date><idno type="doi">10.1111/j.1464-410X.2012.11610.x</idno><idno type="RBID">pubmed:23107074</idno><idno type="pmid">23107074</idno><idno type="wicri:Area/PubMed/Corpus">000333</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000333</idno><idno type="wicri:Area/PubMed/Curation">000333</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000333</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">A comparative study of thulium laser resection of the prostate and bipolar transurethral plasmakinetic prostatectomy for treating benign prostatic hyperplasia.</title><author><name sortKey="Peng, Bo" sort="Peng, Bo" uniqKey="Peng B" first="Bo" last="Peng">Bo Peng</name><affiliation wicri:level="1"><nlm:affiliation>Department of Urology, Shanghai Tenth People's Hospital of Tongji University, Shanghai, 200072, P.R. China.</nlm:affiliation><country xml:lang="fr" wicri:curation="lc">République populaire de Chine</country><wicri:regionArea>Department of Urology, Shanghai Tenth People's Hospital of Tongji University, Shanghai, 200072</wicri:regionArea></affiliation></author><author><name sortKey="Wang, Guang Chun" sort="Wang, Guang Chun" uniqKey="Wang G" first="Guang-Chun" last="Wang">Guang-Chun Wang</name></author><author><name sortKey="Zheng, Jun Hua" sort="Zheng, Jun Hua" uniqKey="Zheng J" first="Jun-Hua" last="Zheng">Jun-Hua Zheng</name></author><author><name sortKey="Xia, Sheng Qiang" sort="Xia, Sheng Qiang" uniqKey="Xia S" first="Sheng-Qiang" last="Xia">Sheng-Qiang Xia</name></author><author><name sortKey="Geng, Jiang" sort="Geng, Jiang" uniqKey="Geng J" first="Jiang" last="Geng">Jiang Geng</name></author><author><name sortKey="Che, Jian Ping" sort="Che, Jian Ping" uniqKey="Che J" first="Jian-Ping" last="Che">Jian-Ping Che</name></author><author><name sortKey="Yan, Yang" sort="Yan, Yang" uniqKey="Yan Y" first="Yang" last="Yan">Yang Yan</name></author><author><name sortKey="Huang, Jian Hua" sort="Huang, Jian Hua" uniqKey="Huang J" first="Jian-Hua" last="Huang">Jian-Hua Huang</name></author><author><name sortKey="Xu, Yun Fei" sort="Xu, Yun Fei" uniqKey="Xu Y" first="Yun-Fei" last="Xu">Yun-Fei Xu</name></author><author><name sortKey="Yang, Bin" sort="Yang, Bin" uniqKey="Yang B" first="Bin" last="Yang">Bin Yang</name></author></analytic><series><title level="j">BJU international</title><idno type="eISSN">1464-410X</idno><imprint><date when="2013" type="published">2013</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Aged</term><term>Aged, 80 and over</term><term>Follow-Up Studies</term><term>Humans</term><term>Laser Therapy (methods)</term><term>Lasers, Solid-State (therapeutic use)</term><term>Length of Stay</term><term>Male</term><term>Middle Aged</term><term>Organ Size</term><term>Pain, Postoperative (physiopathology)</term><term>Patient Safety</term><term>Patient Satisfaction (statistics & numerical data)</term><term>Postoperative Complications (physiopathology)</term><term>Prostatic Hyperplasia (pathology)</term><term>Prostatic Hyperplasia (surgery)</term><term>Quality of Life</term><term>Risk Assessment</term><term>Thulium (therapeutic use)</term><term>Transurethral Resection of Prostate (methods)</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Adulte d'âge moyen</term><term>Complications postopératoires (physiopathologie)</term><term>Douleur postopératoire (physiopathologie)</term><term>Durée du séjour</term><term>Humains</term><term>Hyperplasie de la prostate ()</term><term>Hyperplasie de la prostate (anatomopathologie)</term><term>Lasers à solide (usage thérapeutique)</term><term>Mâle</term><term>Qualité de vie</term><term>Résection transuréthrale de prostate ()</term><term>Satisfaction du patient ()</term><term>Sujet âgé</term><term>Sujet âgé de 80 ans ou plus</term><term>Sécurité des patients</term><term>Taille d'organe</term><term>Thulium (usage thérapeutique)</term><term>Thérapie laser ()</term><term>Études de suivi</term><term>Évaluation des risques</term></keywords><keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Thulium</term></keywords><keywords scheme="MESH" qualifier="anatomopathologie" xml:lang="fr"><term>Hyperplasie de la prostate</term></keywords><keywords scheme="MESH" qualifier="methods" xml:lang="en"><term>Laser Therapy</term><term>Transurethral Resection of Prostate</term></keywords><keywords scheme="MESH" qualifier="pathology" xml:lang="en"><term>Prostatic Hyperplasia</term></keywords><keywords scheme="MESH" qualifier="physiopathologie" xml:lang="fr"><term>Complications postopératoires</term><term>Douleur postopératoire</term></keywords><keywords scheme="MESH" qualifier="physiopathology" xml:lang="en"><term>Pain, Postoperative</term><term>Postoperative Complications</term></keywords><keywords scheme="MESH" qualifier="statistics & numerical data" xml:lang="en"><term>Patient Satisfaction</term></keywords><keywords scheme="MESH" qualifier="surgery" xml:lang="en"><term>Prostatic Hyperplasia</term></keywords><keywords scheme="MESH" qualifier="therapeutic use" xml:lang="en"><term>Lasers, Solid-State</term></keywords><keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr"><term>Lasers à solide</term><term>Thulium</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Aged</term><term>Aged, 80 and over</term><term>Follow-Up Studies</term><term>Humans</term><term>Length of Stay</term><term>Male</term><term>Middle Aged</term><term>Organ Size</term><term>Patient Safety</term><term>Quality of Life</term><term>Risk Assessment</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Adulte d'âge moyen</term><term>Durée du séjour</term><term>Humains</term><term>Hyperplasie de la prostate</term><term>Mâle</term><term>Qualité de vie</term><term>Résection transuréthrale de prostate</term><term>Satisfaction du patient</term><term>Sujet âgé</term><term>Sujet âgé de 80 ans ou plus</term><term>Sécurité des patients</term><term>Taille d'organe</term><term>Thérapie laser</term><term>Études de suivi</term><term>Évaluation des risques</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">WHAT'S KNOWN ON THE SUBJECT? AND WHAT DOES THE STUDY ADD?: Thulium laser is a new generation of surgical laser. It is a minimally invasive technology with several advantages, including rapid vaporization and minimal tissue damage and bleeding. However, details regarding the safety and efficacy of thulium laser in treating BPH remains unknown. We performed a comparative study in 100 patients with BPH of the safety and efficacy of thulium laser resection of the prostate (TMLRP, n = 50) and bipolar transurethral plasmakinetic prostatectomy (TUPKP, n = 50). We found that the efficacy and indications were the same in TMLRP and TUPKP. In TUPKP, the morbidity of urethrostenosis was low, and was nearly bloodless in surgery and had higher safety. Nevertheless, TUPKP is more suitable for patients with larger prostate volume.</div></front></TEI><pubmed><MedlineCitation Owner="NLM" Status="MEDLINE"><PMID Version="1">23107074</PMID><DateCreated><Year>2013</Year><Month>04</Month><Day>04</Day></DateCreated><DateCompleted><Year>2013</Year><Month>05</Month><Day>29</Day></DateCompleted><DateRevised><Year>2013</Year><Month>11</Month><Day>21</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1464-410X</ISSN><JournalIssue CitedMedium="Internet"><Volume>111</Volume><Issue>4</Issue><PubDate><Year>2013</Year><Month>Apr</Month></PubDate></JournalIssue><Title>BJU international</Title><ISOAbbreviation>BJU Int.</ISOAbbreviation></Journal><ArticleTitle>A comparative study of thulium laser resection of the prostate and bipolar transurethral plasmakinetic prostatectomy for treating benign prostatic hyperplasia.</ArticleTitle><Pagination><MedlinePgn>633-7</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1111/j.1464-410X.2012.11610.x</ELocationID><Abstract><AbstractText Label="UNLABELLED">WHAT'S KNOWN ON THE SUBJECT? AND WHAT DOES THE STUDY ADD?: Thulium laser is a new generation of surgical laser. It is a minimally invasive technology with several advantages, including rapid vaporization and minimal tissue damage and bleeding. However, details regarding the safety and efficacy of thulium laser in treating BPH remains unknown. We performed a comparative study in 100 patients with BPH of the safety and efficacy of thulium laser resection of the prostate (TMLRP, n = 50) and bipolar transurethral plasmakinetic prostatectomy (TUPKP, n = 50). We found that the efficacy and indications were the same in TMLRP and TUPKP. In TUPKP, the morbidity of urethrostenosis was low, and was nearly bloodless in surgery and had higher safety. Nevertheless, TUPKP is more suitable for patients with larger prostate volume.</AbstractText><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To compare the safety and short-term efficacy of thulium laser resection of the prostate (TMLRP) and bipolar transurethral plasmakinetic prostatectomy (TUPKP) for the treatment of patients with benign prostatic hyperplasia (BPH).</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">A total of 100 patients diagnosed with BPH were randomly divided into two groups, treated with either TMLRP (50, group 1) or TUPKP (50, group 2). There was no significant difference in preoperative variables such as age, prostate volume, prostate-specific antigen (PSA) level, International Prostate Symptom Score (IPSS), maximum urinary flow rate (Qmax ) and postvoid residual urine volume (PVR) between the two groups. The perioperative parameters and therapeutic effects were recorded and compared between the two groups.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">There were significant differences in the following parameters between the two groups (TMLRP vs TUPKP [mean ± SD]): operation duration, 61.2 ± 24.2 vs 30.14 ± 15.9 min; catheterization time, 1.8 ± 0.4 vs 3.2 ± 0.6 d; postoperative hospital stay, 3.3 ± 0.8 vs 4.1 ± 1.3 d. The volume of blood loss and postoperative bladder irrigation were significantly lower in TMLRP group than in the TUPKP group. At 1 month after the operation, there were four cases of urethral stricture in the TUPKP group. At 3 months after the operation, IPSS, quality of life (QoL), Qmax and PVR were significantly improved, with no significant difference between the two groups.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">TMLRP is superior to TUPKP in terms of safety, blood loss, recovery time and complication rate, and is as efficacious as TUPKP for treating BPH. Operation duration was significantly longer in the TMLRP group than in the TUPKP group.</AbstractText><CopyrightInformation>© 2012 BJU International.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Peng</LastName><ForeName>Bo</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Urology, Shanghai Tenth People's Hospital of Tongji University, Shanghai, 200072, P.R. China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Guang-chun</ForeName><Initials>GC</Initials></Author><Author ValidYN="Y"><LastName>Zheng</LastName><ForeName>Jun-hua</ForeName><Initials>JH</Initials></Author><Author ValidYN="Y"><LastName>Xia</LastName><ForeName>Sheng-qiang</ForeName><Initials>SQ</Initials></Author><Author ValidYN="Y"><LastName>Geng</LastName><ForeName>Jiang</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Che</LastName><ForeName>Jian-ping</ForeName><Initials>JP</Initials></Author><Author ValidYN="Y"><LastName>Yan</LastName><ForeName>Yang</ForeName><Initials>Y</Initials></Author><Author ValidYN="Y"><LastName>Huang</LastName><ForeName>Jian-hua</ForeName><Initials>JH</Initials></Author><Author ValidYN="Y"><LastName>Xu</LastName><ForeName>Yun-fei</ForeName><Initials>YF</Initials></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Bin</ForeName><Initials>B</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2012</Year><Month>10</Month><Day>29</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BJU Int</MedlineTA><NlmUniqueID>100886721</NlmUniqueID><ISSNLinking>1464-4096</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>8RKC5ATI4P</RegistryNumber><NameOfSubstance UI="D013932">Thulium</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName MajorTopicYN="N" UI="D000368">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="N" UI="D000369">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="N" UI="D005500">Follow-Up Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="N" UI="D053685">Laser Therapy</DescriptorName><QualifierName MajorTopicYN="Y" UI="Q000379">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="N" UI="D053844">Lasers, Solid-State</DescriptorName><QualifierName MajorTopicYN="N" UI="Q000627">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="N" UI="D007902">Length of Stay</DescriptorName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="N" UI="D008875">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="N" UI="D009929">Organ Size</DescriptorName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="N" UI="D010149">Pain, Postoperative</DescriptorName><QualifierName MajorTopicYN="N" UI="Q000503">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="N" UI="D061214">Patient Safety</DescriptorName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="N" UI="D017060">Patient Satisfaction</DescriptorName><QualifierName MajorTopicYN="N" UI="Q000706">statistics & numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="N" UI="D011183">Postoperative Complications</DescriptorName><QualifierName MajorTopicYN="N" UI="Q000503">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="N" UI="D011470">Prostatic Hyperplasia</DescriptorName><QualifierName MajorTopicYN="Y" UI="Q000473">pathology</QualifierName><QualifierName MajorTopicYN="Y" UI="Q000601">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="Y" UI="D011788">Quality of Life</DescriptorName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="N" UI="D018570">Risk Assessment</DescriptorName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="N" UI="D013932">Thulium</DescriptorName><QualifierName MajorTopicYN="Y" UI="Q000627">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="N" UI="D020728">Transurethral Resection of Prostate</DescriptorName><QualifierName MajorTopicYN="Y" UI="Q000379">methods</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="aheadofprint"><Year>2012</Year><Month>10</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2012</Year><Month>10</Month><Day>31</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2012</Year><Month>10</Month><Day>31</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2013</Year><Month>5</Month><Day>31</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="doi">10.1111/j.1464-410X.2012.11610.x</ArticleId><ArticleId IdType="pubmed">23107074</ArticleId></ArticleIdList></PubmedData></pubmed></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Terre/explor/ThuliumV1/Data/PubMed/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000333 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd -nk 000333 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Terre
|area= ThuliumV1
|flux= PubMed
|étape= Curation
|type= RBID
|clé= pubmed:23107074
|texte= A comparative study of thulium laser resection of the prostate and bipolar transurethral plasmakinetic prostatectomy for treating benign prostatic hyperplasia.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Curation/RBID.i -Sk "pubmed:23107074" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd \
| NlmPubMed2Wicri -a ThuliumV1
| This area was generated with Dilib version V0.6.21. |  |